According to Vision Research Reports, the global gastrointestinal bleeding treatment market size to reach US$ 850.2 million by 2027 and is projected to expand at a CAGR of 4.8% from 2020 to 2027. Rise in prevalence of gastrointestinal bleeding with age, increase in incidence of re-bleeding cases, and surge in adoption of endoscopic hemostasis as the primary line of treatment for gastrointestinal bleeding contribute to the growth of the global market.
Adoption of Endoscopic Hemostasis as Primary Line of Treatment for GI Bleeding to Propel Segment
The report offers detailed segmentation of the global gastrointestinal bleeding treatment market. Based on product, the market has been segmented into endoscopic hemostatic devices, closure devices, and others. The endoscopic hemostatic devices segment has been categorized into thermal devices and mechanical devices. The endoscopic hemostatic devices segment dominated the market in 2017 and the trend is likely to continue during the forecast period. The segment is expected to grow at a high CAGR from 2018 to 2026. Growth of the segment can be attributed to the usage of endoscopic hemostasis as the primary line of treatment for gastrointestinal bleeding. Rise in demand for these devices is owing to their ability to restore hemostasis in majority of the cases. Moreover, increase in usage of combination therapies contributes to the growth of the segment.
Upper GI Tract Segment to Expand Rapidly
Based on GI tract division, the market has been segregated into upper GI tract and lower GI tract. The upper GI tract segment dominated the market in 2019 and is anticipated to continue to dominate the market during the forecast period. The segment is likely to expand at a high CAGR from 2020 to 2027. Higher rate of hospitalization due to upper GI tract bleeding, higher prevalence than lower GI tract bleeding, and ease of diagnosis of upper GI tract bleeding contribute to the growth of the segment. Moreover, incidence of upper gastrointestinal bleeding rises with age owing to increase in consumption of non-steroidal anti-inflammatory drugs (NSAIDs) which provoke ulcerogenensis in elderly patients.
Hospitals Segment Held Major Share
In terms of end-user, the global gastrointestinal bleeding treatment market has been divided into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held prominent share of the market in 2019. Growth of the segment can be attributed to increase in the rate of hospitalizations and favorable reimbursement policies in hospitals.
Asia Pacific Market to be Driven by Rise in Prevalence of Gastrointestinal Bleeding among Geriatric Population
In terms of revenue, North America dominated the global gastrointestinal bleeding treatment market in 2019. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Growth of the gastrointestinal bleeding treatment market in the region is attributed to increase in geriatric population and rise in prevalence of GI bleeding with age. The primary cause of UGIB in India is oesophagial varices which is reported in over 60% of the patients. Furthermore, the incidence of UGIB increases with age owing to rise in consumption of non-steroidal anti-inflammatory drugs (NSAIDs) which causes ulcerogenensis in elderly patients. The primary causes of LGIB in India are enteric ulcers, followed by neoplasm, tubercular ulcers, angiodysplasia, amoebic ulcers, and others.
Product Launches and Geographic Expansion are Primary Strategies Adopted by Market Players
The report also provides profiles of leading players operating in the global gastrointestinal bleeding treatment market. These include Boston Scientific Corporation, Cook Medical, Olympus Corporation, CONMED Corporation, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, US Endoscopy (a subsidiary of STERIS plc), and US Medical Innovations, LLC. Market players have adopted the strategy of product launches to enhance their customer base. For instance, in 2018, Cook Medical launched its Hemospray in the U.S., a topical agent for the treatment of gastrointestinal bleeding. Broad market presence, cross-selling opportunity, comprehensive product portfolio, and new product launches are the key strategies adopted by leading players in the market.
The report analyzes and forecasts the gastrointestinal bleeding treatment market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of gastrointestinal bleeding treatment, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major gastrointestinal bleeding treatment companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of gastrointestinal bleeding treatment upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of gastrointestinal bleeding treatment and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global gastrointestinal bleeding treatment market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the gastrointestinal bleeding treatment market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of gastrointestinal bleeding treatment market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Key companies operating in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.
The global gastrointestinal bleeding treatment market has been segmented as follows:
Global Gastrointestinal Bleeding Treatment Market, by Product
Global Gastrointestinal Bleeding Treatment Market, by GI Tract Division
Global Gastrointestinal Bleeding Treatment Market, by End-user
Global Gastrointestinal Bleeding Treatment Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms Used
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Product Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Increase in geriatric population
5.2.1.2. Government and non-government funding
5.2.1.3. High prevalence of upper gastrointestinal bleeding
5.2.1.4. Rise in applications of endoscopic hemostasis
5.2.1.5. Significant product launches
5.2.1.6. Strategic acquisitions
5.2.2. Restraints
5.2.2.1. Dearth of skilled labor
5.2.2.2. Product recalls
5.2.2.3. Limitations of endoscopic management
5.2.3. Opportunities
5.2.3.1. Increase in adoption of combination therapy
5.2.3.2. Untapped emerging economies
5.3. Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2018-2026
5.4. Global Gastrointestinal Bleeding Treatment Market Outlook
5.5. Key Industry Developments
5.6. Technological Advancements
5.7. Disease Epidemiological Assessment
5.8. Global Incidence of Gastrointestinal Cancers by Region
5.9. Reimbursement Scenario Assessment
5.10. Strategies Adopted by Top 3 Players
5.11. Healthcare Overview
6. Global Gastrointestinal Bleeding Treatment Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product
6.4. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018-2026
6.4.1. Endoscopic Hemostatic Devices
6.4.1.1. Thermal Devices
6.4.1.2. Mechanical Devices
6.4.2. Closure Devices
6.4.3. Others
6.5. Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018-2026
7. Global Gastrointestinal Bleeding Treatment Market Analysis, by GI Tract Division
7.1. Introduction
7.2. Key Findings
7.3. Market Value Share Analysis, by GI Tract Division
7.4. Market Value Forecast, by Procedure, 2018–2026
7.4.1. Upper GI Tract Division
7.4.2. Lower GI Tract Division
7.5. Market Attractiveness, by GI Tract Division
8. Global Gastrointestinal Bleeding Treatment Market Analysis, by End-user
8.1. Introduction
8.2. Key Findings
8.3. Market Value Share Analysis, by End-user
8.4. Market Value Forecast, by End-user, 2018–2026
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Others
8.5. Market Attractiveness, by End-user
9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecasts, by Region
9.1. Introduction
9.2. Regional Outlook
9.3. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Region, 2018–2026
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region
10. North America Gastrointestinal Bleeding Treatment Market Analysis
10.1. Key Findings
10.2. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Country, 2018-2026
10.2.1. U.S.
10.2.2. Canada
10.3. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018–2026
10.3.1. Endoscopic Hemostatic Devices
10.3.1.1. Thermal Devices
10.3.1.2. Mechanical Devices
10.3.2. Closure Devices
10.3.3. Others
10.4. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2018–2026
10.4.1. Upper GI Tract
10.4.2. Lower GI Tract
10.5. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2018–2026
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. North America Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product
10.6.3. By GI Tract Division
10.6.4. By End-user
11. Europe Gastrointestinal Bleeding Treatment Market Analysis
11.1. Key Findings
11.2. Europe Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2018-2026
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018–2026
11.3.1. Endoscopic Hemostatic Devices
11.3.1.1. Thermal Devices
11.3.1.2. Mechanical Devices
11.3.2. Closure Devices
11.3.3. Others
11.4. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2018–2026
11.4.1. Upper GI Tract
11.4.2. Lower GI Tract
11.5. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2018–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Europe Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Product
11.6.3. By GI Tract Division
11.6.4. By End-user
12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2018-2026
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia
12.2.5. Rest of Asia Pacific
12.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018–2026
12.3.1. Endoscopic Hemostatic Devices
12.3.1.1. Thermal Devices
12.3.1.2. Mechanical Devices
12.3.2. Closure Devices
12.3.3. Others
12.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2018–2026
12.4.1. Upper GI Tract
12.4.2. Lower GI Tract
12.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2018–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Asia Pacific Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Product
12.6.3. By GI Tract Division
12.6.4. By End-user
13. Latin America Gastrointestinal Bleeding Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2018?2026
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018–2026
13.3.1. Endoscopic Hemostatic Devices
13.3.1.1. Thermal Devices
13.3.1.2. Mechanical Devices
13.3.2. Closure Devices
13.3.3. Others
13.4. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2018–2026
13.4.1. Upper GI Tract
13.4.2. Lower GI Tract
13.5. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2018–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Latin America Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Product
13.6.3. By GI Tract Division
13.6.4. By End-user
14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2018?2026
14.2.1. GCC Countries
14.2.2. Israel
14.2.3. South Africa
14.2.4. Rest of Middle East & Africa
14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2018–2026
14.3.1. Endoscopic Hemostatic Devices
14.3.1.1. Thermal Devices
14.3.1.2. Mechanical Devices
14.3.2. Closure Devices
14.3.3. Others
14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2018–2026
14.4.1. Upper GI Tract
14.4.2. Lower GI Tract
14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2018–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Middle East & Africa Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Product
14.6.3. By GI Tract Division
14.6.4. By End-user
15. Competitive Landscape
15.1. Competition Matrix
15.2. Gastrointestinal Bleeding Treatment Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Olympus Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Cook Medical
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Ovesco Endoscopy AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Erbe Elektromedizin GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Steris, plc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. US Medical Innovations, LLC
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers